[DOI] [PubMed] [Google Scholar] 409.Schwartz H., Ollilainen V., Piironen V., Lampi A.M
Significant outlier data points were detected using the Grubbs test and excluded from the analysis
Truth be told, when patients are considering either Trulicity or Mounjaro to lose weight, and not for managing their diabetes, then the better choice would be Mounjaro
There are also a number of lesser-known brands available in pharmacies as well as on Amazon
For someone looking to drop 15 vanity pounds, the cost may not be justified
In a 52 week trial of pediatric insulin experienced type 1 diabetes patients, 84.1% of patients who received TRESIBA were positive at baseline for anti insulin degludec antibodies and 5.8% of patients developed anti insulin degludec antibodies at least once during the trial